ABSTRACT
This cross sectional study was conducted in 2018 in Côte d'Ivoire to assess PrEP acceptability among men who have sex with men (MSM). Two hundred and one men were asked on their intention to use PrEP if made available. Logistic regression accounting for the sampling design was used to analyze associations between high PrEP acceptability and different independent variables including barriers and facilitators. Participants were mostly young (mean age = 25 years), educated (82% with secondary/postsecondary education) and single (95.5%). On average, 3.4 episodes of anal sex were reported monthly and 37.8% of men did not use a condom at last sex. Most MSM (72.6%) had heard of PrEP before enrollment. Overall, 35.3% reported that they would use PrEP very probably if made available. In multivariate analysis, factors associated with high PrEP acceptability were condom use at last sexual intercourse (Odds ratio (OR) = 2.51; 95%Confidence interval (95%CI) = 1.45-4.33); insertive sex as compared to versatile sex (OR = 2.56; 95%CI = 1.14-5.67); free PrEP delivery (OR = 2.45; 95%CI = 1.07-5.59), concerns about side effects (OR = 0.66; 95%CI = 0.48-0.90), and being preoccupied by the fact that post-PrEP antiretroviral therapy could be inefficient (OR = 0.25; 95%CI = 0.14-0.44). PrEP implementation among MSM in Côte d'Ivoire should be accompanied by awareness raising campaigns explaining its utility.
Subject(s)
HIV Infections , Pre-Exposure Prophylaxis , Sexual and Gender Minorities , Adult , Coitus , Cote d'Ivoire , Cross-Sectional Studies , HIV Infections/prevention & control , Homosexuality, Male , Humans , MaleABSTRACT
Introduction : La stéatose hépatique (SH) est un facteur aggravant de l'évolution des hépatites vi-rales chroniques. Le but de ce travail était d'étudier la prévalence et les facteurs associés à la stéa-tose hépatique chez les patients suivis pour hépatites virales. Matériel et méthode: Il s'agissait d'une étude observationnelle de type rétrospectif sur la période du 1er Janvier 2010 au 31 Décembre 2016. Résultats : Sur 440 patients suivis pour hépatite virale B (HVB) et/ou C (HVC), 339 avaient des don-nées échographiques exploitables. La prévalence de la SH était de 10,6%.Il n'y avait pas de diffé-rence significative entre les porteurs de l'HVB (10.2%) et ceux de l'HVC (11.6%), p=0,69. Le diabète (20%), l'hypertension artérielle (18,7%), et les patients ne consommant pas d'alcool (12,4%), sem-blaient plus atteints par la SH mais de façon non significative. La SH était associée à l'obésité(OR=7,36 [2,89-18,73], p<0,001), et au sexe féminin (OR= 2,56 [1,27-5,16], p= 0,008). Conclusion: L'obésité et le sexe féminin représentaient les facteurs de risque trouvés pour la SHdans cette étude
Subject(s)
Benin , Fatty Liver , Patients , PrevalenceABSTRACT
OBJECTIVE: Determine the prevalence of cryptococcal antigenemia and associated factors in HIV-infected patients in Cotonou in order to introduce systematic screening in national guidelines. PATIENTS AND METHODS: This is a cross-sectional, descriptive and analytical study conducted from June to September 2015 in four outpatient treatment centers with adult patients infected with HIV, receiving or not antiretroviral treatment with a number of CD4≤200cell/µL and who have given their informed consent to participate in the study. For each enrolled patient, after signing the informed consent form, it was made a clinical examination and administration of a questionnaire to collect general information, treatment and biological data. Then a blood sample for counting CD4 lymphocytes and the search of cryptococcal antigenemia were done. RESULTS: In total, 355 patients were included in the study with a mean age of 40±10.2years. The overall prevalence of cryptococcal antigenemia is 1.7%. All patient with cryptococcal antigenemia have a CD4 count below 100cells/µL with a majority having CD4 count below 50cells/µL. Body mass index<18.5kg/m2, an alteration of the general condition with a CD4 lymphocyte counts<50cells/µL are the main factors associated with the occurrence of cryptococcal antigenemia. CONCLUSION: This pilot study showed a low prevalence of cryptococcal antigenemia in the study population, but higher in highly immuno-deficient patients with CD4 counts<50cells/µl. Given the results obtained, the introduction of routine screening among patients infected with HIV could be reserved to those with CD4 counts<50cells/µl.
